Skip to main content
. 2023 Sep 13;9(9):e20107. doi: 10.1016/j.heliyon.2023.e20107

Table 3.

Pharmacokinetic study of RLX-PNPs and RLX-suspension in Sprague-Dawley rats.

Pharmacokinetic Parameters RLX-PNPs RLX-Suspension
AUC (μg*h/ml) 2092.83 ± 53.64* 263.81 ± 19.95
Tmax (h) 3.39 ± 0.12* 2.68 ± 0.11
Cmax (μg/ml) 7.38 ± 0.49* 1.02 ± 0.18
t ½ (h) 7.32 ± 0.73 7.15 ± 0.55
Kel(h−1) 5.49 ± 0.51 4.77 ± 0.42

Each value represents the mean ± S.D. (n = 6). *P < 0.05 compared to RLX-Suspension.